National Center for Biotechnology Information, U.S. A meta-analysis of the effect of chromium supplementation on anthropometric indices of subjects with overweight or obesity. Tsang C, Taghizadeh M, Aghabagheri E, Asemi Z, Jafarnejad S. The influences of chromium supplementation on glycemic control, markers of cardio-metabolic risk, and oxidative stress in infertile polycystic ovary syndrome women candidate for in vitro fertilization: A randomized, double-blind, placebo-controlled trial. Jamilian M, Zadeh Modarres S, Amiri Siavashani M, et al.
Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical study. The effects of supplementation with chromium on insulin resistance indices in women with polycystic ovarian syndrome: A systematic review and meta-analysis of randomized clinical trials. Heshmati J, Omani-Samani R, Vesali S, et al. Chromium supplementation and polycystic ovary syndrome: A systematic review and meta-analysis. Chromium supplementation reduces resting heart rate in patients with metabolic syndrome and impaired glucose tolerance. Nussbaumerova B, Rosolova H, Krizek M, et al. Chromium supplements for glycemic control in type 2 diabetes: limited evidence of effectiveness. doi:10.2337/diab.Ĭostello RB, Dwyer JT, Bailey RL. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Chromium.Īnderson RA, Cheng N, Bryden NA, et al. Chromium: Fact sheet for health professionals. Chromium picolinate supplementation for overweight or obese adults. Using the adequate intake for nutrient assessment of groups.
0 kommentar(er)
